By Dr. Bradley McGregor | Published April 02, 2025Renal cell cancer (RCC) treatment continues to evolve, and Tivozanib (TIVO) is…
Browsing: ASCO
Welcome to OncologyTube’s ASCO Page! Here, we deliver the latest videos, expert interviews, and key updates from the American Society of Clinical Oncology (ASCO). Dive into groundbreaking cancer research, treatment advancements, and highlights from ASCO annual meetings and symposiums—all tailored for healthcare professionals like you. Stay ahead with the most current oncology insights, brought to you directly from the heart of clinical progress!
Extended CheckMate-274 Results Show Continued Benefit With Nivolumab in MIBCDate: February 14, 2025Author: Dr. Matthew I. Milowsky, MD, FASCO, University…
Transforming MIBC Treatment: Insights from the NIAGARA TrialPosted on February 16, 2025The landscape of treating muscle-invasive bladder cancer (MIBC) has…
Talazoparib + Enzalutamide Introduction:We are excited to share the latest findings from the TALAPRO-2 Trial, which marks a significant advancement…
Introduction:Recent data from the American Society of Clinical Oncology (ASCO) GI Cancers Symposium 2025, as detailed in their educational book,…
Abstract: Circulating tumor DNA (ctDNA) has a short half-life (<2 hours) which may permit real-time monitoring of tumor status. This…
In the rapidly evolving field of cancer treatment, the application of comprehensive genomic profiling (CGP) via liquid biopsy has become…
In the evolving landscape of cancer careIn the evolving landscape of cancer care, the use of circulating tumor DNA (ctDNA),…
In a recent interview with Dr. Ignacio Garrido-Laguna from the University of Utah Health, we gained fascinating insights into the…
In an enlightening discussion at the latest medical symposium, Dr. Jonathan Nowak, MD from Brigham and Women’s Hospital, shared critical…
By: Elizabeth Catherine Smyth – Cambridge University Hospitals NHS Foundation TrustBackground: Oesophagogastric adenocarcinoma (OGA) remains a significant global health challenge,…
Background: The treatment landscape for well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been slow to evolve, with limited evidence supporting the…
IntroductionASCO 2024 Head & Neck Cancer developments brought forth several groundbreaking studies in the field of head and neck cancer,…
Author: Dr. Shubham Pant, MD – MD AndersonOverview: At the ASCO 2024 conference, Dr. Shubham Pant, MD – MD Anderson…
Author: Dr. Zandra Klippel, Global Product Head, Multiple Myeloma, SanofiAt the ASCO 2024 conference, Dr. Zandra Klippel the Global Product…
Author: Dr. Alexis LeVee, City of HopeAt the ASCO 2024 conference, Dr. Alexis LeVee from City of Hope presented a…
Author: Dr. Regina Barragan-Carillo, City of HopeOverview: At ASCO 2024, Dr. Regina Barragan-Carillo from City of Hope Cancer Center shared…
Presented by Dr. Hedyeh Ebrahimi, City of HopeOverview: At the ASCO 2024 conference, Dr. Hedyeh Ebrahimi of City of Hope…
…Dr. Sumanta (Monty) Kumar Pal, M.D., FASCO highlights some of the top data and presentations being presented in kidney and bladder…
Dr. Omid Hamid from The Angeles Clinic goes over his favorite presentations coming up at ASCO 2024. Should these be…
Howard S. Hochster, MD: [00:00:00] Um, first of all, this is for late line colorectal cancer after the standard chemotherapy…
OncologyTube: [00:00:00] Okay, we’re here at ASCO GI 2024 and we have Dr. Dr. Riccardo Lencioni, MD medical doctor, professor…
Jalen Patel, MD – City of Hopeaugust 21, 2023Drawing from data provided by ASCO and Friends of Cancer Research, the…
Akasha Dukkipati, MD at City of Hope August 21, 2023 Akasha Dukkipati, MD at City of Hope, conducted an analysis…
iFrame is not supported! Lung Cancer: My Top 5 Abstracts to See in Lung Cancer at ASCO 2023 Jack West…
Lung Cancer: My Top 5 Abstracts to See in Lung Cancer at ASCO 2023 By Jack West, MD, associate professor…
iFrame is not supported! Everolimus: Julie Gralow SABCS 2022 SWOG S1207 in HER2- Breast Cancer What is Everolimus and…
Everolimus: Julie Gralow SABCS 2022 SWOG S1207 in HER2- Breast Cancer What is Everolimus and how can it help…
ASCO [2022] Lung Cancer In-Depth Slides: MOASC Dr. Misako Nagasaka’s (thoracic oncology) MOASC Presentation on ASCO (Annual Meeting, American…
ASCO (American Society of Clinical Oncology) [2022] Sarcomas Cancer In-Depth Slides: MOASC Â Dr. Warren Chow’s MOASC Presentation on ASCO…
Question and Answer Session Joseph Chao, MD – ASCO 2022 Esophageal In-Depth Slides: MOASC Spotlight https://oncologytube.com/v/41288 Joseph Chao, MD -…
Question and Answer Session Arash Rezazadeh, MD, ASCO [2022] Genitourinary Cancer: MOASC Oncology Spotlight Link https://oncologytube.com/v/41291 Arash Rezazadeh, MD, ASCO…
ASCO [2022] Genitourinary Cancer(s): MOASC Oncology Spotlight Dr. Arash Rezazadeh’s MOASC 2022 Presentation in Genitourinary Cancers (ASCO genitourinary cancers symposium)…
ASCO 2022 Esophageal In-Depth Slides: MOASC Spotlight  ASCO 2022 Esophageal Cancer Abstracts Highlights Abstracts of interest that were recently…
ASCO 2022 Prostate Cancer Overview: MOASC Spotlight  ARASENS Trial I presented at MOASC three datasets in prostate cancer from…
Dr. Nan Chen from the University of Chicago Medicine shares a status update from ASCO on the quality improvement program…
Platinum Chemotherapy: vs. Temozolomide/Capecitabine for Advanced GEPNENs: ECOG-ACRIN EA2142 Results Jennifer Eads MD By Jennifer Eads, MD So, at ASCO…
Pathologic Complete Response: How may the I-SPY2 trial help HR positive HER2 negative Breast Cancer patients? Laura Huppert By Laura…
T-Vec: + Pembro Advanced Melanoma MASTERKEY-115 Trial Dr Gastman By Brian Gastman, MD The FDA’s approval of multiple drugs for…
KRAS Lung Cancer: Taking on Goliath Discussion by Jai Luo MD By Jai Luo, MD Hi there, my name is…
DCISionRT: Assessing Breast Cancer Adjuvant Endocrine Therapy After BCS Chirag Shah MD By Chirag Shah, MD So this study was…
CEACAM5: Safety and Efficacy Outcome in Long-term Treatment with SAR408701 in Pts with NSQ NSCLC Prof Charles Ricordel By Professor…